Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet (London, England)（2023）
摘要
The National Cancer Center Research and the Ministry of Health, Labour, and Welfare of Japan.
更多查看译文
关键词
biliary tract cancer,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要